Pregabalin Capsule
Product Images NDC 50090-6793

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 50090-6793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500906793)

FDA Label Image

Pregabalinchemistrystructure (Pregabalin Chem Structure)

FDA Label Image

Pregabalin-equation (Pregabalin Equation)

FDA Label Image

Pregabalinfig1 (Pregabalin Fig 01)

FDA Label Image

Pregabalinfig2 (Pregabalin Fig 02)

FDA Label Image

Pregabalinfig3 (Pregabalin Fig 03)

FDA Label Image

Pregabalinfig4 (Pregabalin Fig 04)

FDA Label Image

Pregabalinfig5 (Pregabalin Fig 05)

Pregabalinfig5 (Pregabalin Fig 05)
The text provided seems to indicate the prescription of two medications: Fregabalin 100mg three times a day and Pregataiin 80mg three times a day. There is also a mention of a placebo. The numbers mentioned might be related to the improvement in pain reported by patients, but it is difficult to interpret without further context. Unfortunately, the text is not clear enough to provide a more specific description.*
FDA Label Image

Pregabalin-fig-06 (Pregabalin Fig 06)

FDA Label Image

Pregabalin-fig-07 (Pregabalin Fig 07)

FDA Label Image

Pregabalin-fig-08 (Pregabalin Fig 08)

FDA Label Image

Pregabalin-fig-09 (Pregabalin Fig 09)

FDA Label Image

Pregabalin-fig-10 (Pregabalin Fig 10)

FDA Label Image

Pregabalin-fig-11 (Pregabalin Fig 11)

Pregabalin-fig-11 (Pregabalin Fig 11)
The given text is not readable.*
FDA Label Image

Pregabalin-fig-12 (Pregabalin Fig 12)

Pregabalin-fig-12 (Pregabalin Fig 12)
This text provides information on the percent of subjects improved before and after taking Pregabalin or Placebo. It includes specific data points at weeks 16, with values ranging from 100 to 280.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.